Skip to main content

Advertisement

SpringerLink
Log in

State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms

  • State-of-the-Art Clinical Surgery
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Despite advances in medical therapy, surgery continues to play a vital role in the management of Crohn’s disease and its complications. Continuing from Part I of this series (small intestine/ileal disease), we focus next on colonic Crohn’s disease and associated neoplasms. We will first review the surgical management of medical-refractory Crohn’s colitis and its complications and then examine cancer risk, surveillance, and surgical management of Crohn’s-associated colorectal dysplasia and malignancy. We conclude with a discussion of restoration of gastrointestinal continuity following colonic surgery for Crohn’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Burisch J, Jess T, Martinato M et al (2013) The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7(4):322–337

    PubMed  Google Scholar 

  2. Dahlhamer JM, Zammitti EP, Ward BW et al (2016) Prevalence of inflammatory bowel disease among adults aged ≥18 years - United States, 2015. MMWR Morb Mortal Wkly Rep 65(42):1166–1169

    PubMed  Google Scholar 

  3. Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778

    PubMed  Google Scholar 

  4. Kostic AD, Xavier RJ, Gevers D (2014) The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146(6):1489–1499

    CAS  PubMed  Google Scholar 

  5. Kavalukas SL, Scheurlen KM, Galandiuk S (2022) State-of-the-art surgery for Crohn’s disease: Part I-small intestine/ileal disease. Langenbecks Arch Surg 407:885–895

    PubMed  Google Scholar 

  6. Gajendran M, Loganathan P, Catinella AP et al (2018) A comprehensive review and update on Crohn’s disease. Dis Mon 64(2):20–57

    PubMed  Google Scholar 

  7. Shaffer VO, Wexner SD (2013) Surgical management of Crohn’s disease. Langenbecks Arch Surg 398(1):13–27

    PubMed  Google Scholar 

  8. Mills S, Stamos MJ (2007) Colonic Crohn’s disease. Clin Colon Rectal Surg 20(4):309–313

    PubMed  PubMed Central  Google Scholar 

  9. Roberts H, Rai SN, Pan J et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90(2):122–129

    CAS  PubMed  Google Scholar 

  10. Galandiuk S, Kimberling J, Al-Mishlab TG et al (2005) Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 241(5):796–801 (discussion 801–2)

    PubMed  PubMed Central  Google Scholar 

  11. Cho CW, You MW, Oh CH et al (2021) Long-term disease course of Crohn's disease: changes in disease location, phenotype, activities, and predictive factors. Gut Liver.

  12. Lin SN, Zheng DP, Qiu Y et al (2020) Classifying Crohn’s disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification. Therap Adv Gastroenterol 13:1756284820968732

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Autenrieth DM, Baumgart DC (2012) Toxic megacolon. Inflamm Bowel Dis 18(3):584–591

    PubMed  Google Scholar 

  14. Øresland T, Bemelman WA, Sampietro GM et al (2015) European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis 9(1):4–25

    PubMed  Google Scholar 

  15. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2(4947):1041–1048

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Lightner AL, Vogel JD, Carmichael JC et al (2020) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease. Dis Colon Rectum 63(8):1028–1052

    PubMed  Google Scholar 

  17. Roberts SE, Williams JG, Yeates D et al (2007) Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn’s disease: record linkage studies. BMJ 335(7628):1033

    PubMed  PubMed Central  Google Scholar 

  18. Fornaro R, Caratto E, Caratto M et al (2015) Post-operative recurrence in Crohn’s disease. Critical analysis of potential risk factors. An update. Surgeon 13(6):330–47

    PubMed  Google Scholar 

  19. Netz U, Galbraith NJ, O’Brien S et al (2018) Long-term outcomes following ileal pouch-anal anastomosis in patients with indeterminate colitis. Surgery 163(3):535–541

    PubMed  Google Scholar 

  20. Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A:5a–36a

    PubMed  Google Scholar 

  21. Sinagra E, Orlando A, Mocciaro F et al (2018) Clinical course of severe colitis: a comparison between Crohn’s disease and ulcerative colitis. J Biol Regul Homeost Agents 32(2):415–423

    CAS  PubMed  Google Scholar 

  22. Dignass A, Lindsay JO, Sturm A et al (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 6(10):991–1030

    PubMed  Google Scholar 

  23. Brown SR, Fearnhead NS, Faiz OD et al (2018) The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis 20(Suppl 8):3–117

    PubMed  Google Scholar 

  24. Tapani MJ, Olavi KH (2014) Surgical Management of Toxic Megacolon. Hepatogastroenterology 61(131):638–641

    PubMed  Google Scholar 

  25. Bemelman WA, Warusavitarne J, Sampietro GM et al (2018) ECCO-ESCP Consensus on Surgery for Crohn’s Disease. J Crohns Colitis 12(1):1–16

    PubMed  Google Scholar 

  26. Tekkis PP, Purkayastha S, Lanitis S et al (2006) A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: a meta-analysis. Colorectal Dis 8(2):82–90

    CAS  PubMed  Google Scholar 

  27. Angriman I, Pirozzolo G, Bardini R et al (2017) A systematic review of segmental vs subtotal colectomy and subtotal colectomy vs total proctocolectomy for colonic Crohn’s disease. Colorectal Dis 19(8):e279–e287

    CAS  PubMed  Google Scholar 

  28. Goldberg HI, Caruthers SB Jr, Nelson JA et al (1979) Radiographic findings of the National Cooperative Crohn’s Disease Study. Gastroenterology 77(4 Pt 2):925–937

    CAS  PubMed  Google Scholar 

  29. Yamazaki Y, Ribeiro MB, Sachar DB et al (1991) Malignant colorectal strictures in Crohn’s disease. Am J Gastroenterol 86(7):882–885

    CAS  PubMed  Google Scholar 

  30. Fumery M, Yzet C, Chatelain D et al (2021) Colonic strictures in inflammatory bowel disease: epidemiology, complications, and management. J Crohns Colitis 15(10):1766–1773

    PubMed  Google Scholar 

  31. Chang CW, Wong JM, Tung CC et al (2015) Intestinal stricture in Crohn’s disease. Intest Res 13(1):19–26

    PubMed  PubMed Central  Google Scholar 

  32. Kwon YH, Jeon SW, Lee YK (2013) Endoscopic management of refractory benign colorectal strictures. Clin Endosc 46(5):472–475

    PubMed  PubMed Central  Google Scholar 

  33. American Cancer Society. Cancer Statistics Center. Accessed Jan 8 2022]; Available from: http://cancerstatisticscenter.cancer.org.

  34. Munkholm P (2003) Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 18(Suppl 2):1–5

    PubMed  Google Scholar 

  35. Basseri RJ, Basseri B, Vassilaki ME et al (2012) Colorectal cancer screening and surveillance in Crohn’s colitis. J Crohns Colitis 6(8):824–829

    PubMed  Google Scholar 

  36. von Roon AC, Reese G, Teare J et al (2007) The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum 50(6):839–855

    Google Scholar 

  37. Samadder NJ, Valentine JF, Guthery S et al (2019) Family history associates with increased risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 17(9):1807-1813.e1

    PubMed  Google Scholar 

  38. Keller DS, Windsor A, Cohen R et al (2019) Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol 23(1):3–13

    CAS  PubMed  Google Scholar 

  39. Galandiuk S, Rodriguez-Justo M, Jeffery R et al (2012) Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology 142(4):855-864.e8

    PubMed  Google Scholar 

  40. Ullman T, Odze R, Farraye FA (2009) Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon. Inflamm Bowel Dis 15(4):630–638

    PubMed  Google Scholar 

  41. Magro F, Gionchetti P, Eliakim R et al (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 11(6):649–670

    PubMed  Google Scholar 

  42. Murthy SK, Feuerstein JD, Nguyen GC et al (2021) AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology 161(3):1043-1051.e4

    PubMed  Google Scholar 

  43. Laine L, Kaltenbach T, Barkun A et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81(3):489-501.e26

    PubMed  Google Scholar 

  44. Shergill AK, Lightdale JR, Bruining DH et al (2015) The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 81(5):1101-21.e1–13

    PubMed  Google Scholar 

  45. Abraham BP (2016) Cancer surveillance in ulcerative colitis and Crohn’s disease: new strategies. Curr Opin Gastroenterol 32(1):32–37

    PubMed  Google Scholar 

  46. Choi PM, Nugent FW, Schoetz DJ Jr et al (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105(2):418–424

    CAS  PubMed  Google Scholar 

  47. Lutgens MW, Oldenburg B, Siersema PD et al (2009) Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 101(10):1671–1675

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Bernstein CN, Blanchard JF, Kliewer E et al (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91(4):854–862

    CAS  PubMed  Google Scholar 

  49. Murphy J, Kalkbrenner KA, Pemberton JH et al (2014) Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer. Dis Colon Rectum 57(8):993–998

    PubMed  Google Scholar 

  50. Cremer A, Demetter P, De Vos M et al (2020) Risk of development of more-advanced lesions in patients with inflammatory bowel diseases and dysplasia. Clin Gastroenterol Hepatol 18(7):1528-1536.e5

    PubMed  Google Scholar 

  51. Thomas T, Abrams KA, Robinson RJ et al (2007) Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 25(6):657–668

    CAS  PubMed  Google Scholar 

  52. Kiran RP, Nisar PJ, Goldblum JR et al (2012) Dysplasia associated with Crohn’s colitis: segmental colectomy or more extended resection? Ann Surg 256(2):221–226

    PubMed  Google Scholar 

  53. Maser EA, Sachar DB, Kruse D et al (2013) High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn’s colitis. Inflamm Bowel Dis 19(9):1827–1832

    PubMed  Google Scholar 

  54. Lightner AL, Vogler SA, Vaidya PS et al (2021) The fate of unifocal versus multifocal low-grade dysplasia at the time of colonoscopy in patients with IBD. Dis Colon Rectum 64(11):1364–1373

    PubMed  Google Scholar 

  55. Sensi B, Khan J, Warusavitarne J et al (2021) Long-term oncological outcome of segmental versus extended colectomy for colorectal cancer in Crohn's disease: results from an international multicentre study. J Crohns Colitis.

  56. Bogach J, Pond G, Eskicioglu C et al (2021) Extent of surgical resection in inflammatory bowel disease associated colorectal cancer: a population-based study. J Gastrointest Surg 25(10):2610–2618

    PubMed  Google Scholar 

  57. Braveman JM, Schoetz DJ Jr, Marcello PW et al (2004) The fate of the ileal pouch in patients developing Crohn’s disease. Dis Colon Rectum 47(10):1613–1619

    PubMed  Google Scholar 

  58. Deutsch AA, McLeod RS, Cullen J et al (1991) Results of the pelvic-pouch procedure in patients with Crohn’s disease. Dis Colon Rectum 34(6):475–477

    CAS  PubMed  Google Scholar 

  59. Hercun J, Côté-Daigneault J, Lahaie RG et al (2021) Crohn’s disease after proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum 64(2):217–224

    PubMed  Google Scholar 

  60. Hyman NH, Fazio VW, Tuckson WB et al (1991) Consequences of ileal pouch-anal anastomosis for Crohn’s colitis. Dis Colon Rectum 34(8):653–657

    CAS  PubMed  Google Scholar 

  61. Melton GB, Fazio VW, Kiran RP et al (2008) Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg 248(4):608–616

    PubMed  Google Scholar 

  62. Tekkis PP, Heriot AG, Smith O et al (2005) Long-term outcomes of restorative proctocolectomy for Crohn’s disease and indeterminate colitis. Colorectal Dis 7(3):218–223

    CAS  PubMed  Google Scholar 

  63. Lopez NE, Zaghyian K, Fleshner P (2019) Is there a role for ileal pouch anal anastomosis in Crohn’s disease? Clin Colon Rectal Surg 32(4):280–290

    PubMed  PubMed Central  Google Scholar 

  64. Le Q, Melmed G, Dubinsky M et al (2013) Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn’s disease. Inflamm Bowel Dis 19(1):30–36

    PubMed  Google Scholar 

  65. Shen B, Patel S, Lian L (2010) Natural history of Crohn’s disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 31(7):745–753

    CAS  PubMed  Google Scholar 

  66. Panis Y, Poupard B, Nemeth J et al (1996) Ileal pouch/anal anastomosis for Crohn’s disease. Lancet 347(9005):854–857

    CAS  PubMed  Google Scholar 

  67. Lightner AL, Jia X, Zaghiyan K et al (2021) IPAA in known preoperative Crohn’s disease: a systematic review. Dis Colon Rectum 64(3):355–364

    PubMed  Google Scholar 

  68. Fazio VW, Kiran RP, Remzi FH et al (2013) Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 257(4):679–685

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hiram C. Polk, Jr MD Department of Surgery, Price Institute of Surgical Research, University of Louisville, Louisville, KY, 40292, USA

    Anne Macleod, Sandra L. Kavalukas, Katharina M. Scheurlen & Susan Galandiuk

  2. Division of Colon & Rectal Surgery, Hiram C. Polk Jr MD Department of Surgery, University of Louisville, 550 South Jackson St, Louisville, KY, 40202, USA

    Sandra L. Kavalukas & Susan Galandiuk

Authors
  1. Anne Macleod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra L. Kavalukas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katharina M. Scheurlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Galandiuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AM and KMS performed initial literature review and manuscript preparation. SLK and SG reviewed and revised manuscript.

Corresponding author

Correspondence to Susan Galandiuk.

Ethics declarations

Conflict of interest

Drs. Macleod, Kavalukas, and Scheurlen have no conflict of interest. Dr. Galandiuk is the Editor-in-Chief of the journal Diseases of the Colon and Rectum, is the Director of the Price Institute of Surgical Research, and receives support from AbbVie for clinical research.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Macleod, A., Kavalukas, S.L., Scheurlen, K.M. et al. State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms. Langenbecks Arch Surg 407, 2595–2605 (2022). https://doi.org/10.1007/s00423-022-02572-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-022-02572-y

Keywords

Search

Navigation